CN110652540A - Formula for treating food retention type diabetes and preparation method thereof - Google Patents
Formula for treating food retention type diabetes and preparation method thereof Download PDFInfo
- Publication number
- CN110652540A CN110652540A CN201911051444.7A CN201911051444A CN110652540A CN 110652540 A CN110652540 A CN 110652540A CN 201911051444 A CN201911051444 A CN 201911051444A CN 110652540 A CN110652540 A CN 110652540A
- Authority
- CN
- China
- Prior art keywords
- formula
- type diabetes
- diabetes
- fructus cannabis
- cyclocarya paliurus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a formula for treating food retention type diabetes and a preparation method thereof. The formula for treating food retention type diabetes comprises the following raw materials in parts by weight: 27-35 g of white paeony root, 22-28 g of chicken's gizzard-membrane, 27-35 g of fried hawthorn, 22-28 g of tuckahoe, 22-28 g of cyclocarya paliurus, 8-12 g of fructus cannabis and 8-12 g of bunge cherry seed. The formula is traditional Chinese medicinal materials, the raw materials of the formula are convenient to find and prepare, and meanwhile, the preparation method is simple and can be decocted, so that the food stagnation type diabetes mellitus treatment formula is convenient to prepare and drink; the formula of the invention contains white paeony root, chicken's gizzard-membrane, fried hawthorn, tuckahoe, cyclocarya paliurus, fructus cannabis and bunge cherry seed, wherein the cyclocarya paliurus has a treatment effect on diabetes, and the combination of the white paeony root, the chicken's gizzard-membrane, the fried hawthorn, the fructus cannabis and the bunge cherry seed can dredge intestines and stomach of a food retention type diabetes patient, invigorate stomach, promote digestion, eliminate turbid pathogen and reduce lipid, so that the invention is suitable for the food retention type diabetes patient, ensures the treatment effect and has strong pertinence.
Description
Technical Field
The invention relates to the technical field of a traditional Chinese medicine treatment formula for diabetes, in particular to a treatment formula for food retention type diabetes and a preparation method thereof.
Background
Diabetes usually occurs in middle-aged and people who like thick paste, wine, but some teenagers suffer from the disease. Clinically, the deficiency of yin fluid and the generation of dryness-heat are the basic pathogenesis of diabetes. The name of diabetes is first reported in Nei Jing, Ling Shu & Wu Shi, a "Wen Bing Dan for the weak five zang organs, Bing Xiao", which indicates that the weak five zang organs is an important factor for the occurrence of diabetes. The research and development of the medicine for preventing and treating the diabetes have very important significance, and the social benefit and the economic benefit are huge.
Diabetes mellitus is diabetes mellitus in western medicine, namely insulin deficiency in western medicine, and the basic pathology is metabolic disorder of sugar, protein, fat, water, electrolyte and the like caused by absolute or relative insulin secretion deficiency and glucagon activity increase. The traditional Chinese medicine belongs to the category of diabetes, the pathogenesis of the diabetes is closely related to the three organs of lung, spleen and kidney, the pathogenesis of the diabetes is mainly yin deficiency and dryness-heat, qi and yin loss, and the clinically seen non-insulin-dependent type that middle-aged and old people can not cure for a long time is mainly qi and yin deficiency. Although they are treated by type division, the zang-fu organs are usually related to each other in syndrome differentiation, such as deficiency of both qi and yin, the location of disease is in the lung, and it is seen in the kidney or lung-kidney.
The types of diabetes at present mainly include type A (yin deficiency and dryness heat type appearing in type II diabetes), type B (qi and yin deficiency type appearing in type II diabetes), type C (blood stasis and collateral obstruction type appearing in type II diabetes), type D (dryness heat and lung impairment type appearing in type II diabetes), type F (skin pruritus appearing in type II diabetes), and the like.
The diabetes patients have the phenomenon of polyphagia and polyphagia, so some diabetes patients are food accumulation type diabetes, the food accumulation type diabetes not only has the symptoms of polydipsia, diuresis, polyphagia, emaciation, fatigue and weakness, but also can cause disorder of spleen and stomach receiving, decomposition, transportation and transformation due to polydipsia and polyphagia, so that the indigestion can lead to retention of food in stomach and intestine, and the clinical manifestations are epigastric and abdominal distention and pain, eructation, acid regurgitation, or vomiting, acid and rotten food, anorexia, flatulence, stool, acid and foul odor, or undigested food, thick and greasy tongue fur and slippery pulse.
Therefore, there is a need to provide a formula for treating food retention type diabetes and a preparation method thereof to solve the technical problems.
Disclosure of Invention
The invention provides a formula for treating food retention type diabetes and a preparation method thereof, and solves the problems in the background technology.
In order to solve the technical problems, the invention provides a formula for treating food retention type diabetes, which comprises the following raw materials in parts by weight: 27-35 g of white paeony root, 22-28 g of chicken's gizzard-membrane, 27-35 g of fried hawthorn, 22-28 g of tuckahoe, 22-28 g of cyclocarya paliurus, 8-12 g of fructus cannabis and 8-12 g of bunge cherry seed.
Preferably, the feed comprises the following raw materials in parts by weight: 30 g of white paeony root, 25 g of chicken's gizzard-membrane, 30 g of fried hawthorn, 25 g of tuckahoe, 25 g of cyclocarya paliurus, 10 g of fructus cannabis and 10 g of bunge cherry seed.
A formula for treating food retention type diabetes and a preparation method thereof comprise the following steps:
(1) weighing white paeony root, endothelium corneum gigeriae galli, fried hawthorn, poria cocos, cyclocarya paliurus, fructus cannabis and bunge cherry seed in parts by weight;
(2) putting radix Paeoniae alba, endothelium corneum Gigeriae Galli, fructus crataegi preparata, Poria, cyclocarya paliurus, fructus Cannabis and semen Pruni into casserole, adding clear water, and decocting with slow fire for 30 min;
(3) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(4) adding clear water again, decocting with strong fire until boiling, and decocting with slow fire for 10 min;
(5) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(6) repeating the steps (5) and (6) once;
(7) mixing the liquid medicines obtained in the three times;
(8) the obtained medicinal liquid is taken orally for three times.
Preferably, the amount of water added each time is based on the water level being one centimeter higher than the drug level.
Preferably, the three obtained liquid medicines are respectively put into different containers.
In the invention, the properties, the taste, the meridian tropism and the efficacy of each raw material are as follows:
white peony root: bitter and sour, slightly cold in nature; entering liver and spleen meridians; nourishing blood, regulating menstruation, astringing yin, arresting sweating, softening liver, relieving pain, and suppressing liver yang;
endothelium corneum gigeriae galli: sweet and mild; entering spleen, stomach, small intestine and bladder meridians; promoting digestion, invigorating stomach, arresting seminal emission and relieving enuresis;
and (3) frying the hawthorn: sour and sweet in taste, slightly warm in nature; spleen, stomach and liver meridians entered; promoting digestion, invigorating stomach, promoting qi circulation, removing blood stasis, eliminating turbid pathogen, and reducing blood lipid;
tuckahoe, poria cocos: sweet, bland and neutral in flavor; the heart, lung, spleen and kidney meridians are entered;
cyclocarya paliurus: slightly bitter and warm in nature; unknown; clearing heat and relieving swelling;
fructus cannabis: sweet in taste and mild in nature; spleen, stomach and large intestine meridians entered; loosening bowel to relieve constipation, moistening dryness and killing parasites;
the Chinese dwarf cherry seeds: bitter taste and mild nature; spleen, large intestine and small intestine meridians entered; moistening dryness, smoothing intestine, descending qi, promoting the circulation of qi, inducing diuresis to alleviate edema.
Compared with the related technology, the treatment formula for food retention type diabetes and the preparation method thereof provided by the invention have the following beneficial effects:
1. the invention provides a formula for treating food retention type diabetes and a preparation method thereof.
2. The invention provides a treatment formula of food retention type diabetes and a preparation method thereof, the formula comprises radix paeoniae alba, endothelium corneum gigeriae galli, fried hawthorn, poria cocos, cyclocarya paliurus, fructus cannabis and bunge cherry seed, wherein the cyclocarya paliurus has a treatment effect on the diabetes, and the combination of the radix paeoniae alba, the endothelium corneum gigeriae galli, the fried hawthorn, the fructus cannabis and the bunge cherry seed can dredge intestines and stomach of food retention type diabetes patients, invigorate stomach, promote digestion, eliminate turbid pathogen and reduce lipid, so that the food retention type diabetes is suitable for the food retention type diabetes patients, the treatment effect is ensured, and the pertinence is strong.
Detailed Description
The present invention will be further described with reference to the following embodiments.
A formula for treating food retention type diabetes comprises the following raw materials in parts by weight: 30 g of white paeony root, 25 g of chicken's gizzard-membrane, 30 g of fried hawthorn, 25 g of tuckahoe, 25 g of cyclocarya paliurus, 10 g of fructus cannabis and 10 g of bunge cherry seed.
A preparation method of a formula for treating food retention type diabetes comprises the following steps:
(1) weighing 30 g of white paeony root, 25 g of chicken's gizzard-membrane, 30 g of fried hawthorn, 25 g of tuckahoe, 25 g of cyclocarya paliurus, 10 g of fructus cannabis and 10 g of bunge cherry seed in parts by weight;
(2) putting radix Paeoniae alba, endothelium corneum Gigeriae Galli, fructus crataegi preparata, Poria, cyclocarya paliurus, fructus Cannabis and semen Pruni into casserole, adding clear water, and decocting with slow fire for 30 min;
(3) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(4) adding clear water again, decocting with strong fire until boiling, and decocting with slow fire for 10 min;
(5) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(6) repeating the steps (5) and (6) once;
(7) mixing the liquid medicines obtained in the three times;
(8) the obtained medicinal liquid is taken orally for three times.
Specifically, the amount of water added each time is based on the water level being one centimeter higher than the medicine level.
Specifically, the liquid medicines obtained in the three times are respectively put into different containers.
In the present invention, the properties, the channels, the pharmacodynamic action and the therapeutic effects of the raw materials are as follows;
white peony root: bitter and sour, slightly cold in nature; entering liver and spleen meridians; nourishing blood, regulating menstruation, astringing yin, arresting sweating, softening liver, relieving pain, and suppressing liver yang; considering that abdominal pain is easy to occur when intestines and stomach of a patient suffering from food stagnation type diabetes are blocked, the radix paeoniae alba has a certain curative effect on the abdominal pain, and because paeoniflorin contained in the radix paeoniae alba has a good spasmolytic effect, the radix paeoniae alba has an analgesic effect, and meanwhile, the radix paeoniae alba can also benefit yin and nourish blood, and has a certain health care effect on the body of the patient, so that the physique of the patient is improved, and the rehabilitation therapy of the patient is facilitated;
endothelium corneum gigeriae galli: sweet and mild; entering spleen, stomach, small intestine and bladder meridians; promoting digestion, invigorating stomach, arresting seminal emission and relieving enuresis; the endothelium corneum Gigeriae Galli contains gastric hormone, keratin, trace pepsin, amylase, multiple vitamins and microelements, and 18 kinds of amino acids, etc., and is beneficial for digestion of patients, and can be used together with parched fructus crataegi to improve its curative effect, and has better therapeutic effect on food stagnation type diabetes;
and (3) frying the hawthorn: sour and sweet in taste, slightly warm in nature; spleen, stomach and liver meridians entered; promoting digestion, invigorating stomach, promoting qi circulation, removing blood stasis, eliminating turbid pathogen, and reducing blood lipid; the fried hawthorn is a main raw material for treating food retention symptoms of the food retention type diabetes patients in the formula, contains fatty acid, can promote fat digestion, increases secretion of gastric digestive enzyme to promote digestion, has a certain adjustment effect on gastrointestinal functions, can expand coronary arteries, increase coronary flow and protect myocardial ischemia and anoxia; and can strengthen heart, lower blood pressure and resist arrhythmia; the traditional Chinese medicine composition can be used for treating the symptoms of food retention type diabetes patients by adding the stir-fried hawthorn.
Tuckahoe, poria cocos: sweet, bland and neutral in flavor; the heart, lung, spleen and kidney meridians are entered; the poria cocos has the effects of protecting the liver, reducing gastric secretion and inhibiting gastric ulcer, the liver of a patient can be protected by adding the poria cocos, the polysaccharide in the poria cocos has the effect of enhancing the immune function, the physique of the patient can be improved, the liver of the patient can be protected, as the liver is an important digestive organ, a plurality of digestive enzymes can be secreted and can be discharged to an intestinal tract for aiding digestion through bile, the liver also has the effect of regulating sugar, glycogen can be stored, the glycogen can be decomposed to generate blood sugar when the blood sugar is low, the blood sugar can be kept at a good level, and the glycogen can be synthesized to reduce the blood sugar when the blood sugar is too high, so that the curative effect of the formula of the invention can be improved by adding the poria cocos;
cyclocarya paliurus: slightly bitter and warm in nature; unknown; clearing heat and relieving swelling; the coumarins and flavonoids in cyclocarya paliurus have effects of reducing blood sugar, resisting cancer and bacteria, improving blood circulation, and protecting permeability of blood vessel; the medicine also has the function of lowering blood pressure, the mechanism is to recover the structure and the function of pathological islet cells and increase insulin receptors of peripheral tissues, so that the medicine is greatly helpful for treating diabetes, the immunity of a patient can be increased, and the occurrence of complications of the patient can be reduced by matching with dogwood;
fructus cannabis: sweet in taste and mild in nature; spleen, stomach and large intestine meridians entered; loosening bowel to relieve constipation, moistening dryness and killing parasites; the fructus cannabis has the main effects of relaxing bowel for the food retention type diabetes patients, facilitating the smoothness of intestines and stomach of the patients, reducing blood fat and cholesterol, and improving the physique of the patients by reducing the blood fat and the cholesterol aiming at polydipsia and polyphagia of the food retention type diabetes;
the Chinese dwarf cherry seeds: bitter taste and mild nature; spleen, large intestine and small intestine meridians entered; moistening dryness, smoothing intestine, descending qi, promoting the circulation of qi, inducing diuresis, and relieving swelling; the bunge cherry seeds also have the effects of relaxing bowels, promoting urination, relieving pain and the like, and have a certain sedative effect, and patients can sleep after taking the liquid medicine.
And (3) observation of clinical curative effect:
firstly, selecting a medical record: 100 patients with diabetes were selected for clinical observation, and patients were randomly divided into two groups, 50 treatment groups, wherein 28 men and 22 women were aged 40-75 years, the average age was 53 years, the course of disease was 1-5 years, and the average age was 3.5 years; the disease of 50 control groups, 30 men, 20 women, the age of 40-75 years, the average age of 54 years, 1-6 years of disease and the average age of 3.7 years are basically consistent and comparable, and the diet of two groups is controlled according to the requirements.
II, a test method: the patients in the treatment group take the Chinese herbal preparation (prepared according to the formula) for oral administration, one dose of the Chinese herbal preparation is decocted with water for one time a day, 3 times a day, 14 days are a treatment course, the Chinese herbal preparation is continuously taken for 2-6 treatment courses, and the dosage is increased for patients with serious illness; the control group used the diabetes pill, as indicated.
Thirdly, judging the curative effect:
(1) and curing: the symptoms of polydipsia, polyphagia, polyuria and emaciation of the diabetes disappear, and the blood sugar is normal;
(2) and (3) improvement: the symptoms of polydipsia, polyphagia, polyuria and emaciation of the thirst disease disappear or are slightly accurate, and the blood sugar does not fluctuate;
(3) and (3) invalidation: no change in clinical symptoms.
Fourthly, test results:
treatment groups: 35 cases are cured, 12 cases are improved, 3 cases are invalid, the cure rate is 70%, and the total effective rate is 94%.
Control group: 32 cases are cured, 10 cases are improved, 8 cases are not effective, the cure rate is 64 percent, and the total effective rate is 84 percent.
The above results show that: the cure rate and the total effective rate of the treatment group are obviously higher than those of the control group.
Typical cases are:
case one: male, 49 years old, suffering from diabetes for more than 1 year, polydipsia, polyphagia, diuresis, emaciation, distending pain in stomach, constipation, nausea and vomiting, and diagnosing diabetes by checking that the blood sugar is 9.1 mmol/L; after taking the Chinese herbal preparation (prepared according to the formula) of the invention for 4 courses, the symptoms disappear, the blood sugar and urine sugar are normal, the follow-up is carried out later, the relapse does not exist, and the clinical recovery is realized.
Case two: yang Ying, male, 69 years old, has diabetes for more than 3 years, thirst and polydipsia, dry mouth, bitter taste, emaciation, abdominal distension and constipation, and is diagnosed as diabetes by checking 11.01mmol/L of blood sugar; after taking the Chinese herbal preparation (prepared according to the formula) of the invention for 5 courses, the symptoms disappear, the blood sugar and urine sugar are normal, the follow-up is carried out later, the relapse does not exist, and the clinical recovery is realized.
Case three: zhangyi, female, 51 years old, repeated thirst, dry mouth, polydipsia, polyphagia, without regard, aggravated in nearly 3 months, accompanied by nausea, vomiting, constipation, abdominal distension; the diabetes is diagnosed by checking the blood sugar to be 9.8 mmol/L; after taking the Chinese herbal preparation (prepared according to the formula) of the invention for 3 courses, the symptoms disappear, the blood sugar and urine sugar are normal, the follow-up is carried out later, the relapse is avoided, and the clinical recovery is realized.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
The preferred embodiments of the invention disclosed above are intended to be illustrative only. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best utilize the invention. The invention is limited only by the claims and their full scope and equivalents.
Claims (5)
1. A formula for treating food retention type diabetes is characterized in that: the composite material comprises the following raw materials in parts by weight: 27-35 g of white paeony root, 22-28 g of chicken's gizzard-membrane, 27-35 g of fried hawthorn, 22-28 g of tuckahoe, 22-28 g of cyclocarya paliurus, 8-12 g of fructus cannabis and 8-12 g of bunge cherry seed.
2. The formula for treating food retention type diabetes according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 30 g of white paeony root, 25 g of chicken's gizzard-membrane, 30 g of fried hawthorn, 25 g of tuckahoe, 25 g of cyclocarya paliurus, 10 g of fructus cannabis and 10 g of bunge cherry seed.
3. The formulation for treating food stagnation type diabetes and the preparation method thereof according to any one of claims 1-2, characterized by comprising the following steps:
(1) weighing white paeony root, endothelium corneum gigeriae galli, fried hawthorn, poria cocos, cyclocarya paliurus, fructus cannabis and bunge cherry seed in parts by weight;
(2) putting radix Paeoniae alba, endothelium corneum Gigeriae Galli, fructus crataegi preparata, Poria, cyclocarya paliurus, fructus Cannabis and semen Pruni into casserole, adding clear water, and decocting with slow fire for 30 min;
(3) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(4) adding clear water again, decocting with strong fire until boiling, and decocting with slow fire for 10 min;
(5) expelling the liquid medicine from the marmite and pouring the liquid medicine into a container;
(6) repeating the steps (5) and (6) once;
(7) mixing the liquid medicines obtained in the three times;
(8) the obtained medicinal liquid is taken orally for three times.
4. The method of claim 3, wherein the amount of water added per time is based on a centimeter above the level of the water.
5. The formulation for treating food stagnation type diabetes according to claim 3 and the preparation method thereof, wherein the three obtained liquid medicines are respectively put into different containers.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911051444.7A CN110652540A (en) | 2019-10-31 | 2019-10-31 | Formula for treating food retention type diabetes and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911051444.7A CN110652540A (en) | 2019-10-31 | 2019-10-31 | Formula for treating food retention type diabetes and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110652540A true CN110652540A (en) | 2020-01-07 |
Family
ID=69042607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911051444.7A Pending CN110652540A (en) | 2019-10-31 | 2019-10-31 | Formula for treating food retention type diabetes and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110652540A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101999484A (en) * | 2010-10-21 | 2011-04-06 | 铜陵市松马食品包装机械制造有限责任公司 | Hypoglycemic health protection tea and preparation method thereof |
| CN102172385A (en) * | 2011-01-12 | 2011-09-07 | 涂传荣 | Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat |
| CN104887900A (en) * | 2015-05-13 | 2015-09-09 | 河南省新境界酒业有限公司 | Health care wine with effects of fat reducing and weight losing |
-
2019
- 2019-10-31 CN CN201911051444.7A patent/CN110652540A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101999484A (en) * | 2010-10-21 | 2011-04-06 | 铜陵市松马食品包装机械制造有限责任公司 | Hypoglycemic health protection tea and preparation method thereof |
| CN102172385A (en) * | 2011-01-12 | 2011-09-07 | 涂传荣 | Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat |
| CN104887900A (en) * | 2015-05-13 | 2015-09-09 | 河南省新境界酒业有限公司 | Health care wine with effects of fat reducing and weight losing |
Non-Patent Citations (2)
| Title |
|---|
| 吴虹 等: "健脾纳胃汤治疗糖尿病胃轻瘫80 例临床观察", 《河北中医》 * |
| 徐明生 等: "青钱柳水提物降血糖作用研究", 《营养学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998843A (en) | Medicinal composition for treating cholecystitis | |
| CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN102178884A (en) | Chinese medicine preparation for regulating weakness of spleen and stomach of people with deficiency of vital energy, preparation method and application thereof | |
| CN107441409A (en) | Chinese medicine composition for treating habitual constipation and preparation method thereof | |
| CN102188685A (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN108704108A (en) | A kind of medicine pill for treating gout | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN102178866A (en) | Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof | |
| CN110652540A (en) | Formula for treating food retention type diabetes and preparation method thereof | |
| CN105381441A (en) | Traditional Chinese medicine capsule for preventing and treating cyesedema and preparation method of traditional Chinese medicine capsule | |
| CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
| CN104001070A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN104491316B (en) | A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate | |
| CN108837010A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating elderly constipation | |
| CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
| CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
| CN105477067A (en) | Traditional Chinese medicine composition for treating dampness obstructing spleen-stomach type infantile jaundice | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN105796886A (en) | Pharmaceutical composition capable of treating chronic constipation | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof | |
| CN104887949B (en) | A kind of Chinese medicine preparation for the treatment of DCM (dilated cardiomyopathy) and preparation method thereof | |
| CN105343629B (en) | A kind of Chinese medicine composition and preparation method thereof for treating cardiac insufficiency | |
| CN104491556B (en) | A kind of Chinese medicine composition for the treatment of caused by hepatic stagnation qi stagnation prostatic hyperplasia | |
| CN113769018A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
| CN118304369A (en) | Traditional Chinese medicine composition for treating phlegm stagnation type hyperuricemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |